DARO focuses on stopping swine disease outbreaks through advanced molecular pathogen and genomic strain surveillance.
DARO has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in July 2026.
DARO's investors include Invest Nebraska, MOVE Venture Capital, Nebraska Angel Network, LaunchLNK.
DARO is headquartered in Lincoln, United States.
DARO focuses on stopping swine disease outbreaks through advanced molecular pathogen and genomic strain surveillance.
DARO is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DARO — Funding & Investors." VCBacked, July 6, 2026, https://www.vcbacked.co/company/daro. Accessed September 30, 2026.
VCBacked. (2026). DARO — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/daro
{{cite web |title=DARO — Funding & Investors |url=https://www.vcbacked.co/company/daro |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated